Chromatin modified protein 4C (CHMP4C) facilitates the malignant development of cervical cancer cells
- PMID: 32406588
- PMCID: PMC7327912
- DOI: 10.1002/2211-5463.12880
Chromatin modified protein 4C (CHMP4C) facilitates the malignant development of cervical cancer cells
Abstract
Despite improvements in prevention and treatment, cervical cancer (CC) still poses a serious threat to women's health. CHMP4C (chromatin modified protein 4C) is a subunit of the endosomal sorting complex required for transport, which is expressed in both nucleus and cytoplasm. Here, we examined the effect of CHMP4C on the biological behavior of CC cells and the underlying mechanisms. We report that CHMP4C expression is higher in CC tissues, and high CHMP4C expression is associated with lower survival. Up-regulation of CHMP4C in C-33A cells accelerates cell proliferation, migration and invasion, whereas down-regulation of CHMP4C in Ca Ski cells had the opposite effect. Moreover, overexpression of CHMP4C induced activation of the epithelial-mesenchymal transition pathway, whereas depletion of CHMP4C inhibited activation. Our results suggest that CHMP4C contributes to the viability and motility of CC cells by modulating epithelial-mesenchymal transition and may facilitate the identification of novel biomarkers for CC therapy.
Keywords: EMT; cervical cancer; chromatin modified protein 4C; proliferation.
© 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
A cancer-associated polymorphism in ESCRT-III disrupts the abscission checkpoint and promotes genome instability.Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8900-E8908. doi: 10.1073/pnas.1805504115. Epub 2018 Sep 4. Proc Natl Acad Sci U S A. 2018. PMID: 30181294 Free PMC article.
-
Chromatin-modifying protein 4C (CHMP4C) affects breast cancer cell growth and doxorubicin resistance as a potential breast cancer therapeutic target.J Antibiot (Tokyo). 2024 Feb;77(2):93-101. doi: 10.1038/s41429-023-00683-2. Epub 2023 Nov 22. J Antibiot (Tokyo). 2024. PMID: 37993600
-
CHMP4C Disruption Sensitizes the Human Lung Cancer Cells to Irradiation.Int J Mol Sci. 2015 Dec 24;17(1):18. doi: 10.3390/ijms17010018. Int J Mol Sci. 2015. PMID: 26712741 Free PMC article.
-
Exploring the clinical and biological significance of the cell cycle-related gene CHMP4C in prostate cancer.BMC Med Genomics. 2024 Aug 13;17(1):210. doi: 10.1186/s12920-024-01970-z. BMC Med Genomics. 2024. PMID: 39138470 Free PMC article.
-
Chmp4c is required for stable kinetochore-microtubule attachments.Chromosoma. 2018 Dec;127(4):461-473. doi: 10.1007/s00412-018-0675-8. Epub 2018 Jul 2. Chromosoma. 2018. PMID: 29968190
Cited by
-
Identification and Validation a Necroptosis-Related Prognostic Signature in Cervical Cancer.Reprod Sci. 2023 Jun;30(6):2003-2015. doi: 10.1007/s43032-022-01155-y. Epub 2022 Dec 28. Reprod Sci. 2023. PMID: 36576713
-
A Novel Defined Necroptosis-Related Genes Prognostic Signature for Predicting Prognosis and Treatment of Osteosarcoma.Biochem Genet. 2024 Apr;62(2):831-852. doi: 10.1007/s10528-023-10446-1. Epub 2023 Jul 17. Biochem Genet. 2024. PMID: 37460861
-
Identification of Vesicle-Mediated Transport-Related Genes for Predicting Prognosis, Immunotherapy Response, and Drug Screening in Cervical Cancer.Immun Inflamm Dis. 2024 Nov;12(11):e70052. doi: 10.1002/iid3.70052. Immun Inflamm Dis. 2024. PMID: 39513664 Free PMC article.
-
Analysis of cell death-related genes to evaluate the prognostic and immunotherapeutic value in bladder cancer.Heliyon. 2024 Jun 17;10(12):e33200. doi: 10.1016/j.heliyon.2024.e33200. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 39005901 Free PMC article.
-
Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer.Front Genet. 2023 Jan 6;13:1061107. doi: 10.3389/fgene.2022.1061107. eCollection 2022. Front Genet. 2023. PMID: 36685937 Free PMC article.
References
-
- Torre LA, Islami F, Siegel RL, Ward EM and Jemal A (2017) Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev 26, 444–457. - PubMed
-
- Shafabakhsh R, Reiter RJ, Mirzaei H, Teymoordash SN and Asemi Z (2019) Melatonin: a new inhibitor agent for cervical cancer treatment. J Cell Physiol 234, 21670–21682. - PubMed
-
- Tsu V and Jeronimo J (2016) Saving the World's women from cervical cancer. N Engl J Med 374, 2509–2511. - PubMed
-
- Sadri Nahand J, Moghoofei M, Salmaninejad A, Bahmanpour Z, Karimzadeh M, Nasiri M, Mirzaei HR, Pourhanifeh MH, Bokharaei‐Salim F, Mirzaei H and et al (2020) Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: a review. Int J Cancer 146, 305–320. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
